Search DrRajHealth

Saturday, April 8, 2017

Trial of new triple inhaler shows 20% reduction in COPD flare-ups

We don't have a "tripple inhaler" on the market yet. But, many with COPD are on these classes of medications through current available options. These maintenance medications are not fast-acting, that is, you may not feel much of a difference today versus tomorrow with use, but they work to stabilize lung function and symptoms over the long term. This means you have to stick with them and compliantly use as prescribed to realize benefit. http://ift.tt/1VMjaZw
from Rajesh Harrykissoon, MD